Ja joins S Africans in health research
The Eden Gardens Group has formed a strategic public-private partnership with a number of South African science and technology stakeholders to conduct joint research and development in mutually agreed areas such as cancer and nutraceuticals, and to facilitate the transfer of technology in both countries. They are the Republic of South Africa's Department of Science and Technology, Technology Innovation Agency (TIA), House of Hemp and University of Free State (UFS).
The Eden Gardens Group - which includes Bio-tech R&D Institute, Medicanja Ltd, Eden Gardens and E.G. Wellness Brands - is a pioneer in the research and development of products from indigenous Jamaican plants, and also in introducing and developing the health and wellness ecosystem locally.
TIA is a national public entity that serves as the key institutional intervention to bridge the innovation gap between research and development from higher education institutions, science councils, public entities and private sector, and commercialisation.
"As the ministry (Ministry of Science and Technology) further cements its relationship with the government of the Republic of South Africa, we are very pleased to be a part of it and share in this mutually beneficial relationship," said Dr Henry Lowe, executive chairman of The Eden Gardens Group.
"This partnership comes at a time when we are looking to expand our brand and share our valued expertise with the rest of the world, and we are looking forward to what we will be able to achieve through this agreement."
The partnership will be for an initial period of five years and is being established under the existing bilateral agreement between the governments of the Republic of South Africa and Jamaica. Key features of the partnership include a science exchange programme for postgraduate students, current knowledge sharing, intellectual property, product development, technological transfer and commercialisation.